What's new

Human medicines European public assessment report (EPAR): Cyramza, ramucirumab, Date of authorisation: 19/12/2014, Revision: 21, Status: Authorised

Human medicines European public assessment report (EPAR): Cyramza, ramucirumab, Date of authorisation: 19/12/2014, Revision: 21, Status: Authorised

Jun 18, 2025 - 11:05
 0
Human medicines European public assessment report (EPAR): Cyramza, ramucirumab, Date of authorisation: 19/12/2014, Revision: 21, Status: Authorised
Human medicines European public assessment report (EPAR): Cyramza, ramucirumab, Date of authorisation: 19/12/2014, Revision: 21, Status: Authorised
Read More

Tags:

Previous Article

Aptose CEO props up biotech's finances to prevent company from going bust

Next Article

Medicine evaluation figures

Related Posts

Human medicines European public assessment report (EPAR): Opdivo, nivolumab, Date of authorisation: 19/06/2015, Revision: 67, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 2, 2025  0

Summary of opinion: NexGard Combo, 15/05/2025 Positive

Summary of opinion: NexGard Combo, 15/05/2025 Positive

May 16, 2025  0

Human medicines European public assessment report (EPAR): Matever, levetiracetam, Date of authorisation: 03/10/2011, Revision: 28, Status: Authorised

Human medicines European public assessment report (EPAR...

May 16, 2025  0